APOA1 and Miyoshi myopathy: In this study, a metabolomics analysis showed lower levels of total apolipoprotein-A1, HDL-4 Apolipoprotein-A1, and HDL-4 Apolipoprotein-A2 in MM patients compared to healthy controls.